A missense variant in Epidermal Growth Factor EGF (p.Pro1096Thr), the upstream regulator of the NRAS/KRAS pathway, is predicted pathogenic by SIFT/PolyPhen-2 but has not been reported in association with cancer by the COSMIC or TCGA datasets. The gene discussed is NRAS; the disease is cancer.